Literature DB >> 1372913

Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.

M Laurell1, A Christensson, P A Abrahamsson, J Stenflo, H Lilja.   

Abstract

An assay was developed for the measurement of human protein C inhibitor antigen (PCI) in blood plasma and other biological fluids. Both native PCI, modified inhibitor, and complexes of inhibitor with activated protein C or plasma kallikrein could be measured with the assay. Inhibitor antigen concentrations were found to be very high in seminal plasma (greater than 200 mg/liter), more than 40 times the concentration of PCI found in blood plasma. The inhibitor in seminal plasma was unable to form complexes with activated protein C. Gel filtration and immunoblotting findings indicated that the inhibitor in seminal plasma is present in a high molecular mass complex or cleaved to its modified form. As PCI antigen was absent from seminal plasma of patients with dysfunctional seminal vesicles, the seminal vesicle glands would appear to be the major source of seminal plasma PCI, a conclusion supported by immunohistochemical demonstration of the presence of PCI epitopes in the secretory epithelium of the seminal vesicles. Specific PCI immunoreactivity was also shown to be present in the testes, the epididymis glands, and the prostate, suggesting the inhibitor to have a complex or multiple function in the male reproductive system. Conclusive evidence of a local synthesis of PCI in the four male sex glands was provided by Northern blot analysis of RNA from these organs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372913      PMCID: PMC442965          DOI: 10.1172/JCI115689

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Evidence for a glycine residue at position 316 in human protein C inhibitor.

Authors:  J C Meijers; D W Chung
Journal:  Thromb Res       Date:  1990-07-15       Impact factor: 3.944

2.  Purification and characterization of plasma protein C inhibitor.

Authors:  F España; M Berrettini; J H Griffin
Journal:  Thromb Res       Date:  1989-08-01       Impact factor: 3.944

Review 3.  The roles of protein C and thrombomodulin in the regulation of blood coagulation.

Authors:  C T Esmon
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

4.  Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa.

Authors:  H Lilja; P A Abrahamsson; A Lundwall
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

5.  High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen.

Authors:  P Chapdelaine; G Paradis; R R Tremblay; J Y Dubé
Journal:  FEBS Lett       Date:  1988-08-15       Impact factor: 4.124

6.  Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex.

Authors:  D C Stump; M Thienpont; D Collen
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

7.  Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.

Authors:  J C Meijers; D H Kanters; R A Vlooswijk; H E van Erp; M Hessing; B N Bouma
Journal:  Biochemistry       Date:  1988-06-14       Impact factor: 3.162

8.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

9.  Protein C inhibitor. Purification from human plasma and characterization.

Authors:  K Suzuki; J Nishioka; S Hashimoto
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

10.  Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.

Authors:  J Chmielewska; M Rånby; B Wiman
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

View more
  27 in total

Review 1.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

2.  Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex.

Authors:  H Deguchi; H Takeya; E C Gabazza; J Nishioka; K Suzuki
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Regulation of the human protein C inhibitor gene expression in HepG2 cells: role of Sp1 and AP2.

Authors:  T Hayashi; M Usui; J Nishioka; Z X Zhang; K Suzuki
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

4.  Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.

Authors:  Ákos Végvári; Melinda Rezeli; Carina Sihlbom; Jari Häkkinen; Elisabet Carlsohn; Johan Malm; Hans Lilja; Thomas Laurell; György Marko-Varga
Journal:  Clin Biochem       Date:  2011-12-16       Impact factor: 3.281

5.  Interaction of activated protein C with serpins.

Authors:  J M Hermans; S R Stone
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

6.  Extrahepatic expression and regulation of protein C in the mouse.

Authors:  K Yamamoto; D J Loskutoff
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  Expression patterns of protein C inhibitor in mouse development.

Authors:  Gerry T M Wagenaar; Pavel Uhrin; Klara Weipoltshammer; Marlene Almeder; Pieter S Hiemstra; Margarethe Geiger; Joost C M Meijers; Christian Schöfer
Journal:  J Mol Histol       Date:  2010-03-14       Impact factor: 2.611

8.  Effects of season and dietary ascorbic acid on some biochemical characteristics of rainbow trout (Oncorhynchus mykiss) semen.

Authors:  A Ciereszko; L Liu; K Dabrowski
Journal:  Fish Physiol Biochem       Date:  1996-02       Impact factor: 2.794

Review 9.  Structure, function, and regulation of the enzyme activity of prostate-specific antigen.

Authors:  H Lilja
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.